Voyageur Pharmaceuticals (CVE:VM) Trading Up 50% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares rose 50% on Thursday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares changed hands during mid-day trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Stock Up 50.0 %

The firm has a 50 day moving average of C$0.07 and a two-hundred day moving average of C$0.06. The stock has a market capitalization of C$14.64 million, a PE ratio of -10.50 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.